|
HU212435B
(en)
|
1990-06-07 |
1996-06-28 |
Sandoz Ag |
Herbicidal compositions containing substituted phthalides and heterocyclic phthalides as active ingredient and process for preparation of their active ingredients.
|
|
PT707567E
(pt)
|
1993-07-09 |
2002-01-30 |
Schering Corp |
Processo de sintese de azetidinonas
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
JPH08295646A
(ja)
|
1995-04-26 |
1996-11-12 |
Teijin Ltd |
ビス(ヒドロキシエトキシフェニル)化合物の製造方法
|
|
CN1072649C
(zh)
|
1995-09-13 |
2001-10-10 |
武田药品工业株式会社 |
苯并氧杂吖庚因化合物,其生产方法和用途
|
|
US6187774B1
(en)
|
1996-03-04 |
2001-02-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and pharmaceutical applications thereof
|
|
AU5907898A
(en)
|
1997-01-13 |
1998-08-03 |
Penn State Research Foundation, The |
Asymmetric synthesis and catalysis with chiral heterocyclic compounds
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
US6628343B1
(en)
|
1997-05-23 |
2003-09-30 |
Sony Corporation |
Television signal reception circuit, automatic phase shift control circuit and equal amplitude addition circuit
|
|
IT1292461B1
(it)
|
1997-07-03 |
1999-02-08 |
Great Lakes Chemical Italia |
Composti fotocromatici,procedimento per la loro preparazione e loro utilizzo in materiali polimerici
|
|
ID26984A
(id)
|
1998-07-06 |
2001-02-22 |
Bristol Myers Squibb Co |
Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
|
|
HK1051137A1
(zh)
|
1999-07-09 |
2003-07-25 |
Isis Innovation Limited |
抑制疾病的化合物和製備移植用的細胞
|
|
AR035016A1
(es)
|
1999-08-25 |
2004-04-14 |
Takeda Chemical Industries Ltd |
Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
EP1302462A4
(en)
|
2000-07-17 |
2007-07-18 |
Takeda Pharmaceutical |
SULFONATE DERIVATIVES, PROCESS FOR PRODUCTION AND USE THEREOF
|
|
US7256201B2
(en)
|
2000-12-07 |
2007-08-14 |
Astrazeneca Ab |
Selective estrogen receptor-β ligands
|
|
BR0116468A
(pt)
|
2000-12-08 |
2004-06-29 |
Ortho Mcneil Pharm Inc |
Compostos de pirrolina substituìda por indazolila como inibidores de cinase
|
|
CA2450555A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
US7192939B2
(en)
|
2002-01-30 |
2007-03-20 |
Montana State University |
Pestalotiopsis microsporia isolates and compounds derived therefrom
|
|
WO2003072197A1
(en)
|
2002-02-27 |
2003-09-04 |
Pfizer Products Inc. |
Acc inhibitors
|
|
KR20050043967A
(ko)
|
2002-09-17 |
2005-05-11 |
액테리온 파마슈티칼 리미티드 |
1-피리딘-4-일-요소 유도체
|
|
BR0315815A
(pt)
|
2002-11-01 |
2005-09-13 |
Takeda Pharmaceutical |
Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto
|
|
AU2003277576A1
(en)
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
|
US20070004736A1
(en)
|
2002-11-22 |
2007-01-04 |
Keiji Kubo |
Imidazole derivative, process for producing the same, and use
|
|
US7820837B2
(en)
|
2003-05-30 |
2010-10-26 |
Takeda Pharmaceutical Company Limited |
Condensed ring compound
|
|
WO2004107958A2
(en)
|
2003-05-30 |
2004-12-16 |
Schering Corporation |
Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
|
|
SG146683A1
(en)
|
2003-09-17 |
2008-10-30 |
Janssen Pharmaceutica Nv |
Fused heterocyclic compounds as serotonin receptor modulators
|
|
EP1669352A4
(en)
|
2003-09-30 |
2008-12-17 |
Takeda Pharmaceutical |
THIAZOLINE DERIVATIVE AND ITS USE
|
|
WO2005058823A1
(ja)
|
2003-12-17 |
2005-06-30 |
Takeda Pharmaceutical Company Limited |
ウレア誘導体、その製造法及び用途
|
|
JP2007537141A
(ja)
|
2003-12-18 |
2007-12-20 |
ノボ ノルディスク アクティーゼルスカブ |
新規なglp−1化合物
|
|
WO2005066136A1
(en)
|
2003-12-22 |
2005-07-21 |
Eli Lilly And Company |
Bicyclic derivatives as ppar modulators
|
|
US7456218B2
(en)
|
2003-12-25 |
2008-11-25 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl) propanoic acid derivatives
|
|
WO2005063725A1
(ja)
|
2003-12-26 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
フェニルプロパン酸誘導体
|
|
WO2005087710A1
(ja)
|
2004-03-15 |
2005-09-22 |
Takeda Pharmaceutical Company Limited |
アミノフェニルプロパン酸誘導体
|
|
JP4859665B2
(ja)
|
2004-03-30 |
2012-01-25 |
武田薬品工業株式会社 |
アルコキシフェニルプロパン酸誘導体
|
|
WO2005112932A2
(en)
|
2004-05-07 |
2005-12-01 |
Exelixis, Inc. |
Raf modulators and methods of use
|
|
TWI396686B
(zh)
|
2004-05-21 |
2013-05-21 |
Takeda Pharmaceutical |
環狀醯胺衍生物、以及其製品和用法
|
|
GEP20094723B
(en)
|
2004-05-25 |
2009-07-10 |
Pfizer Prod Inc |
Tetraazabenzo [e] azulene derivatives and analogs thereof
|
|
US7569580B2
(en)
|
2004-06-03 |
2009-08-04 |
Rigel Pharmaceuticals, Inc. |
Heterotricyclic compounds for use as HCV inhibitors
|
|
US20050287100A1
(en)
|
2004-06-08 |
2005-12-29 |
Lebre Caroline |
Cosmetic composition comprising a semi-crystalline polymer and a dispersion of polymer in fatty phase
|
|
GB0419481D0
(en)
|
2004-09-02 |
2004-10-06 |
Cancer Rec Tech Ltd |
Isoindolin-1-one derivatives
|
|
BRPI0515532A
(pt)
|
2004-09-21 |
2008-07-29 |
Athersys Inc |
composto, composição farmacêutica, métodos de inibir a ligação de ligandos endógenos ao receptor de crth-2 em uma célula, de tratar, melhorar ou prevenir um distúrbio responsivo à inibição da ligação de ligandos endógenos ao receptor de crt-2 e de preparar um composto, e, kit
|
|
US20060275288A1
(en)
|
2005-01-20 |
2006-12-07 |
Grihalde Nelson D |
GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
|
|
EP2305246B1
(en)
|
2005-01-31 |
2015-08-26 |
The Trustees of the University of Pennsylvania |
Tumor necrosis factor inhibitors
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
|
AU2006271781A1
(en)
|
2005-07-15 |
2007-01-25 |
F. Hoffmann-La Roche Ag |
Novel heteroaryl fused cyclic amines
|
|
EP1916234B1
(en)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
|
US20090054435A1
(en)
|
2005-07-29 |
2009-02-26 |
Hiroshi Imoto |
Phenoxyalkanoic Acid Compound
|
|
JP4094660B1
(ja)
|
2005-08-10 |
2008-06-04 |
武田薬品工業株式会社 |
糖尿病治療剤
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
BRPI0618523A2
(pt)
|
2005-11-11 |
2011-09-06 |
Hoffmann La Roche |
compostos de aminas cìclicas fundidas carbocìclicas, composições farmacêuticas e usos dos mesmos
|
|
BRPI0707718A2
(pt)
|
2006-02-10 |
2011-05-10 |
Summit Corp Plc |
uso de um composto
|
|
EP2010520B1
(en)
|
2006-04-20 |
2012-09-12 |
Pfizer Products Inc. |
Heterobicyclic amides for the prevention and treatment of glucokinase-mediated diseases
|
|
AU2007265966B2
(en)
|
2006-06-27 |
2012-05-17 |
Takeda Pharmaceutical Company Limited |
Fused cyclic compounds
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
EP2046333A4
(en)
|
2006-07-24 |
2010-09-15 |
Glaxosmithkline Llc |
THIOZOLIDINEDIONE DERIVATIVES AS INHIBITORS OF P13-KINASE
|
|
EP2298772A1
(en)
|
2006-10-18 |
2011-03-23 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds
|
|
CN101573357B
(zh)
|
2006-10-19 |
2013-01-23 |
武田药品工业株式会社 |
吲哚化合物
|
|
AU2007315848A1
(en)
|
2006-11-03 |
2008-05-08 |
Glenmark Pharmaceuticals S.A. |
Bridged bicyclic indazoles as cannabinoid receptor ligands
|
|
WO2008065508A1
(en)
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Spiroketone acetyl-coa carboxylase inhibitors
|
|
EA200900821A1
(ru)
|
2006-12-22 |
2010-02-26 |
Новартис Аг |
Производные 1-аминометил-l-фенилциклогексана как ингибиторы дпп-iv (дипептидилпептидазы-iv)
|
|
WO2008093639A1
(ja)
|
2007-01-29 |
2008-08-07 |
Takeda Pharmaceutical Company Limited |
ピラゾール化合物
|
|
AU2008215490A1
(en)
|
2007-02-09 |
2008-08-21 |
Takeda Pharmaceutical Company Limited |
Fused ring compounds as partial agonists of PPAR-gamma
|
|
GB0706072D0
(en)
|
2007-03-28 |
2007-05-09 |
Sterix Ltd |
Compound
|
|
JPWO2008136428A1
(ja)
|
2007-04-27 |
2010-07-29 |
武田薬品工業株式会社 |
含窒素5員複素環化合物
|
|
EP2157859A4
(en)
|
2007-06-19 |
2011-01-12 |
Takeda Pharmaceutical |
INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE
|
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
US20100292292A1
(en)
|
2007-09-13 |
2010-11-18 |
Link Medicine Corporation |
Treatment of Neurodegenerative Diseases Using Indatraline Analogs
|
|
CN101998959B
(zh)
|
2008-02-06 |
2013-08-28 |
生物马林药物股份有限公司 |
聚(adp-核糖)聚合酶(parp)的苯并噁唑甲酰胺抑制剂
|
|
AU2009233711B2
(en)
|
2008-04-09 |
2015-02-12 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
EP2297164A1
(en)
|
2008-05-28 |
2011-03-23 |
Pfizer Inc. |
Pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルCoAカルボキシラーゼ阻害剤
|
|
ES2558842T3
(es)
|
2008-06-17 |
2016-02-09 |
Indiana University Research And Technology Corporation |
Agonistas mixtos a base de GIP para el tratamiento de trastornos metabólicos y obesidad
|
|
CA2729581A1
(en)
|
2008-07-29 |
2010-02-04 |
Pfizer Inc. |
Fluorinated heteroaryls
|
|
ES2380408T3
(es)
|
2008-08-28 |
2012-05-11 |
Pfizer Inc. |
Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
|
|
US8735391B2
(en)
|
2008-09-26 |
2014-05-27 |
University Of Kansas |
Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
|
|
TW201038580A
(en)
|
2009-02-02 |
2010-11-01 |
Pfizer |
4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
|
|
EP2393810A1
(en)
|
2009-02-05 |
2011-12-14 |
Schering Corporation |
Phthalazine-containing antidiabetic compounds
|
|
WO2010103437A1
(en)
|
2009-03-11 |
2010-09-16 |
Pfizer Inc. |
Benzofuranyl derivatives used as glucokinase inhibitors
|
|
EP2406230A1
(en)
|
2009-03-11 |
2012-01-18 |
Pfizer Inc. |
Substituted indazole amides and their use as glucokinase activators
|
|
CA2754523A1
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
|
EP2427448A1
(en)
|
2009-05-08 |
2012-03-14 |
Pfizer Inc. |
Gpr 119 modulators
|
|
CA2759843A1
(en)
|
2009-05-08 |
2010-11-10 |
Pfizer Inc. |
Gpr 119 modulators
|
|
GEP20135907B
(en)
|
2009-06-05 |
2013-08-12 |
Pfizer |
L-(piperidin-4-yl)-pyrazole derivatives as gpr 119 modulators
|
|
US20120148586A1
(en)
|
2009-08-27 |
2012-06-14 |
Joyce Ching Tsu Chou |
Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
|
|
US8455516B2
(en)
|
2010-01-15 |
2013-06-04 |
Touro University |
HIV-1 fusion inhibitors and methods
|
|
US20120021979A1
(en)
|
2010-06-24 |
2012-01-26 |
Vanderbilt University |
GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
|
|
DK2621493T3
(en)
|
2010-09-30 |
2016-10-24 |
Pfizer |
N1 PYRAZOLOSPIROKETON-ACETYL-CoA carboxylase INHIBITORS
|
|
WO2012065065A1
(en)
|
2010-11-12 |
2012-05-18 |
Follica, Inc. |
Methods and compositions for modulating hair growth, wound healing and scar revision
|
|
JP5805982B2
(ja)
|
2011-04-20 |
2015-11-10 |
ユニチカ株式会社 |
ポリアリレート樹脂フィルムおよび気体分離膜
|
|
JP5687120B2
(ja)
|
2011-04-20 |
2015-03-18 |
ユニチカ株式会社 |
ポリアリレート樹脂
|
|
JP6126097B2
(ja)
|
2011-09-06 |
2017-05-10 |
ノヴォ ノルディスク アー/エス |
Glp−1誘導体
|
|
KR101401705B1
(ko)
|
2012-01-31 |
2014-06-27 |
울산대학교 산학협력단 |
로듐 촉매를 이용한 이소인돌린 유도체의 합성방법
|
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
|
WO2014055634A1
(en)
|
2012-10-02 |
2014-04-10 |
Yale University |
Identification of small molecule inhibitors of jumonji at-rich interactive domain 1a (jarid1a) and 1b (jarid1b) histone demethylase
|
|
WO2014101120A1
(en)
|
2012-12-28 |
2014-07-03 |
Merck Sharp & Dohme Corp. |
Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
|
|
JP6314335B2
(ja)
|
2013-02-06 |
2018-04-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新しいインダニルオキシジヒドロベンゾフラニル酢酸
|
|
JP6573604B2
(ja)
|
2013-06-11 |
2019-09-11 |
セルジーン インターナショナル ツー エスエーアールエル |
新規なglp−1レセプターモジュレーター
|
|
CN103421006B
(zh)
|
2013-08-18 |
2016-06-22 |
上海师范大学 |
2,3,5,7-四取代二氢吡唑并六氢吡啶衍生物及其制备方法和应用
|
|
EP2857550A1
(en)
|
2013-10-02 |
2015-04-08 |
Basf Se |
Amine precursors for depositing graphene
|
|
CN107074820B
(zh)
|
2014-07-25 |
2021-05-18 |
赛尔基因第二国际有限公司 |
Glp-1受体调节剂
|
|
EP2993174A1
(en)
*
|
2014-09-08 |
2016-03-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Pyrazolopyridine derivatives and their use in therapy
|
|
CN105646459A
(zh)
|
2014-11-13 |
2016-06-08 |
上海和辉光电有限公司 |
一种化合物及其制备方法和应用
|
|
WO2016118639A1
(en)
|
2015-01-20 |
2016-07-28 |
The Trustees Of Columbia University In The City Of New York |
Small molecule oxidizers of pdi and their use
|
|
JP6712323B2
(ja)
|
2015-12-31 |
2020-06-17 |
ハンミ ファーマシューティカル カンパニー リミテッド |
グルカゴン、glp−1及びgip受容体のすべてに活性を有する三重活性体
|
|
CN108884041A
(zh)
|
2016-04-22 |
2018-11-23 |
沙特基础工业全球技术有限公司 |
2-芳基-3,3-双(4-羟基芳基)苯并吡咯酮的制备方法,以及由其衍生的聚合物
|
|
WO2017182986A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
WO2017182983A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
JOP20190060A1
(ar)
*
|
2016-09-26 |
2019-03-26 |
Chugai Pharmaceutical Co Ltd |
مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
WO2018109607A1
(en)
*
|
2016-12-16 |
2018-06-21 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
CN120267671A
(zh)
|
2017-03-31 |
2025-07-08 |
奥锐金肿瘤有限公司 |
用于治疗血液病的化合物和组合物
|
|
TWI782056B
(zh)
|
2017-07-14 |
2022-11-01 |
日商鹽野義製藥股份有限公司 |
具有mgat2抑制活性的縮合環衍生物
|
|
JP7461104B2
(ja)
|
2017-11-29 |
2024-04-03 |
中外製薬株式会社 |
Glp-1受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
|
|
MX2020006459A
(es)
|
2017-12-22 |
2020-11-06 |
Chemocentryx Inc |
Compuestos de anillos fusionados 6,5 diaril sustituidos como inhibidores de c5ar.
|
|
PE20211273A1
(es)
|
2018-02-01 |
2021-07-19 |
Japan Tobacco Inc |
Compuesto de amida heterociclica nitrogenada y su uso para fines medicos
|
|
CN112105357A
(zh)
|
2018-02-16 |
2020-12-18 |
Ucb生物制药有限责任公司 |
药用6,5杂双环衍生物
|
|
JP2021514982A
(ja)
|
2018-02-28 |
2021-06-17 |
ノバルティス アーゲー |
インドール−2−カルボニル化合物及びb型肝炎治療のためのそれらの使用
|
|
US20190284340A1
(en)
|
2018-03-14 |
2019-09-19 |
SABIC Global Technologies B.V |
3-oxo-2-arylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
US20190284341A1
(en)
|
2018-03-14 |
2019-09-19 |
Sabic Global Technologies B.V. |
3-oxo-2-alkylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
ES2993034T3
(en)
*
|
2018-04-02 |
2024-12-20 |
Chemocentryx Inc |
Prodrugs of fused-bicyclic c5ar antagonists
|
|
CA3045644C
(en)
|
2018-06-13 |
2024-01-16 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
FI3806855T3
(fi)
|
2018-06-15 |
2023-05-04 |
Pfizer |
Glp-1 -reseptorin agonisteja ja niiden käyttöjä
|
|
WO2020001321A1
(en)
|
2018-06-27 |
2020-01-02 |
The Hong Kong Polytechnic University |
Compounds with antimicrobial activity
|
|
US11923622B2
(en)
|
2018-08-02 |
2024-03-05 |
Nokia Solutions And Networks Oy |
Antenna and wireless communication device
|
|
JP7161605B2
(ja)
|
2018-08-31 |
2022-10-26 |
ファイザー・インク |
Nash/nafldおよび関連疾患の治療のための組合せ
|
|
AR116947A1
(es)
|
2018-11-02 |
2021-06-30 |
Aicuris Gmbh & Co Kg |
Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
|
|
UY38434A
(es)
|
2018-11-02 |
2020-05-29 |
Aicuris Gmbh & Co Kg |
Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
|
|
EA202191432A1
(ru)
|
2018-11-22 |
2021-10-14 |
Цилу Регор Терапьютикс Инк. |
Агонисты glp-1r и их применения
|
|
CN111217796B
(zh)
|
2018-11-26 |
2021-12-14 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷/二吡咯甲川化合物及其制备方法和应用
|
|
CN111217842B
(zh)
|
2018-11-26 |
2023-01-31 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷硼配合物/二吡咯甲川硼配合物及其制备方法和应用
|
|
EP3890748A4
(en)
|
2018-12-05 |
2022-12-21 |
Viking Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES
|
|
WO2020135513A1
(zh)
|
2018-12-25 |
2020-07-02 |
上海美悦生物科技发展有限公司 |
一种作为irak抑制剂的化合物
|
|
WO2020163236A1
(en)
|
2019-02-04 |
2020-08-13 |
The General Hospital Corporation |
Treating long qt syndrome
|
|
AU2020256647B2
(en)
|
2019-04-12 |
2025-07-31 |
Qilu Regor Therapeutics Inc. |
GLP-1R agonists and uses thereof
|
|
CA3140972C
(en)
|
2019-05-20 |
2024-06-18 |
Pfizer Inc. |
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
|
|
TWI751585B
(zh)
|
2019-06-28 |
2022-01-01 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2021018023A1
(zh)
|
2019-08-01 |
2021-02-04 |
济南泰达领创医药技术有限公司 |
小分子glp-1受体调节剂
|
|
CN110804059B
(zh)
|
2019-09-30 |
2024-03-12 |
郑州泰基鸿诺医药股份有限公司 |
氨基甲酸酯类化合物、药物组合物及其应用
|
|
CR20220178A
(es)
|
2019-10-25 |
2022-06-15 |
Gilead Sciences Inc |
Compuestos moduladores de glp-1r
|
|
ES3029360T3
(en)
|
2019-11-15 |
2025-06-24 |
Ildong Pharmaceutical Co Ltd |
Glp-1 receptor agonist and use thereof
|
|
PT4097099T
(pt)
|
2020-02-07 |
2024-07-19 |
Gasherbrum Bio Inc |
Agonistas heterocíclicos de glp-1
|
|
CN115697999A
(zh)
|
2020-02-13 |
2023-02-03 |
加舒布鲁姆生物公司 |
杂环glp-1激动剂
|
|
WO2021219019A1
(en)
|
2020-04-29 |
2021-11-04 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|